Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study-Reference-Cited by-同舟云学术

Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study

Published:2009-09 Issue:3 Volume:155 Page:369-373
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Chase H. Peter,Lutz Karen,Pencek Richard,Zhang Bei,Porter Lisa

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference24 articles.

1. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007,2007

2. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial;J Pediatr,1994

3. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes;Levine;J Pediatr,2001

4. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries;Mortensen;Diabetes Care,1997

5. Factors associated with glycemic control: a cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group;Rosilio;Diabetes Care,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data;Computer Methods and Programs in Biomedicine;2024-02

2. THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin – physiology and pharmacology;European Journal of Endocrinology;2022-06-01

3. A Review of the Efficacy and Cardiovascular Safety of Amylin Analogues;Current Drug Safety;2021-06-08

4. Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms;Endocrine Reviews;2018-07-27

5. Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy;Clinical Pharmacology: Advances and Applications;2018-03